title: High-dose chemotherapy and autologous stem cell transplantation for breast cancer.
authors.affiliation: Response Technologies, Memphis, TN 38117, USA.
authors.forename: C H
authors.initials: CH
authors.lastname: Weaver
authors.forename: R
authors.initials: R
authors.lastname: Birch
authors.forename: L S
authors.initials: LS
authors.lastname: Schwartzberg
authors.forename: W H
authors.initials: WH
authors.lastname: West
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016465:Bone Marrow Purging; D001943:Breast Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009367:Neoplasm Staging; D011379:Prognosis; D015996:Survival Rate; D014182:Transplantation, Autologous
chemical_list: D000970:Antineoplastic Agents; D016298:Hematopoietic Cell Growth Factors